Development of Primary Endpoints for Rare Gene Therapy Clinical Studies: The Lovo-Cel Case Study
Time: 2:15 pm
day: Day 2 CLINICAL PM
Details:
- Reviewing the selection of endpoints for lovo-cel clinical studies
- Exploring the background and impact of changes made to endpoints during clinical development
- Future direction of clinical endpoints as the use of genetic therapies expands
